Cite
HARVARD Citation
Geelen, I. et al. (2018). Omitting cytogenetic assessment from routine treatment response monitoring in chronic myeloid leukemia is safe. European journal of haematology. pp. 367-371. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Geelen, I. et al. (2018). Omitting cytogenetic assessment from routine treatment response monitoring in chronic myeloid leukemia is safe. European journal of haematology. pp. 367-371. [Online].